While activating mutations in the PI3K gene are common in various metabolic diseases and cancers, which may result in metabolic disorders, in the context of diabetes, its dysfunction is often characterized by abnormally weakened downstream AKT signaling. The gene discussed is AKT1; the disease is diabetes mellitus.